Avita Medical’s product heals donors 30% faster

Company News

by Jessica Amir

Avita Medical (ASX:AVH) has advised its new randomised skin trial shows that its ReCell product has healed donors 30 per cent faster.

The regenerative medical company’s study was on 106 patients who received skin grafts.

It’s the company’s third positive clinical trial of late and it found superior wound healing and improved aesthetic appearance.

Avita Medical says its pleased the data shows its ReCell product, can be used to both reduce patient trauma and heal patients much quicker.

Shares in Avita Medical (ASX:AVH) are trading flat at 8 cent.
 

Jessica Amir

Finance News Network
Jessica is a senior finance journalist and presents the Market Outlook, Market at Midday and Market Wrap. She also presents ASX company news and interviews CEOs. She joined FNN in January 2017 with six years of broadcast journalism experience. She worked as a journalist and producer with Sky News Business, ABC 1, ABC's The Business and ABC24. She also worked in regional Australia for Prime 7 and WIN News as a TV reporter. In her prior life she worked as a financial planner.